News
Minnesota Vikings linebacker Dallas Turner, in his second NFL season, was reportedly scammed out of $240,000. A caller posing ...
A fresh earnings season is kicking off this coming week, with Big Banks leading the way on Tuesday and Wednesday. Asking for ...
According to Bloomberg, China’s Industrial and Commercial Bank of China (ICBC) is at the top of this list with assets of 6.7 trillion dollars. It is the largest of the “big four” banks in China, and ...
However, valuation is not a reason to short a good company without a near-term downward catalyst. The reason for this can be summed up by an old Wall Street adage that is attributed to the British ...
Wall Street braces for weakest earnings season since mid-2023 amidst optimism and trade war concerns
US stocks have swung from a dramatic April selloff to new heights. Now, traders are about to see if Corporate America’s report cards justify the optimism priced into equity markets. Expectations ...
The iShares S&P 500 ex Top 100 ETF, meanwhile, tracks the S&P 500 performance excluding the 100 largest stocks, better known ...
Explore more
The fees levied by JPMorgan will depend on how the fintech companies use the data. Payment-focused companies will have to pay ...
10h
Korea JoongAng Daily on MSNJP Morgan: Kospi to hit 5,000 ‘over a two year period’We continue to recommend adding on any volatility as long as the reform process remains on track,” JP Morgan Chase wrote. “Any volatility in global-regional equities over the summer — on tariff ...
JPMorgan Chase chief executive Jamie Dimon thinks the U.S. Federal Reserve could actually raise rates, contrary to popular ...
JPMorgan Chase & Co. has told financial-technology companies that it will start charging fees amounting to hundreds of millions of dollars for access to their customers’ bank account information – a ...
The banking giant plans to start charging for access its customers' data, according to Bloomberg, citing anonymous sources.
17h
The Sunday Guardian Live on MSNAnthem RAISES Rs 1,016 cr from anchor investorsAnthem Biosciences has raised Rs 1,016 crore from anchor investors ahead of its initial share-sale opening for public subscription.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results